The therapeutic potential of regulatory T cells for the treatment of autoimmune disease
- PMID: 25881491
- DOI: 10.1517/14728222.2015.1037282
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease
Abstract
Introduction: Immune tolerance remains the holy grail of therapeutic immunology in the fields of organ and tissue transplant rejection, autoimmune diseases, and allergy and asthma. We have learned that FoxP3(+)CD4(+) regulatory T cells play a vital role in both the induction and maintenance of self-tolerance.
Areas covered: In this opinion piece, we highlight regulatory T cells (Treg) cell biology and novel immune treatments to take advantage of these cells as potent therapeutics. We discuss the potential to utilize Treg and Treg-friendly therapies to replace current general immunosuppressives and induce tolerance as a path towards a drug-free existence without associated toxicities.
Expert opinion: Finally, we opine on the fact that biomedicine sits on the cusp of a new revolution: the use of human cells as versatile therapeutic engines. We highlight the challenges and opportunities associated with the development of a foundational cellular engineering science that provides a systematic framework for safely and predictably regulating cellular behaviors. Although Treg therapy has become a legitimate clinical treatment, development of the therapy will require a better understanding of the underlying Treg biology, manufacturing advances to promote cost effectiveness and combinations with other drugs to alter the pathogenicity/regulatory balance.
Keywords: autoimmunity; cell therapy; organ transplantation; peripheral tolerance; regulatory T cells; suppressor cells.
Similar articles
-
The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.Clin Exp Immunol. 2019 Jul;197(1):24-35. doi: 10.1111/cei.13288. Epub 2019 Mar 24. Clin Exp Immunol. 2019. PMID: 30830965 Free PMC article. Review.
-
Stabilizing human regulatory T cells for tolerance inducing immunotherapy.Immunotherapy. 2017 Aug;9(9):735-751. doi: 10.2217/imt-2017-0017. Epub 2017 Aug 3. Immunotherapy. 2017. PMID: 28771099 Review.
-
Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.Front Immunol. 2021 May 14;12:661875. doi: 10.3389/fimmu.2021.661875. eCollection 2021. Front Immunol. 2021. PMID: 34054826 Free PMC article. Review.
-
Manipulating regulatory T cells: a promising strategy to treat autoimmunity.Immunotherapy. 2015;7(11):1201-11. doi: 10.2217/imt.15.79. Epub 2015 Nov 16. Immunotherapy. 2015. PMID: 26568117 Free PMC article. Review.
-
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7. Proc Natl Acad Sci U S A. 2016. PMID: 27410049 Free PMC article.
Cited by
-
Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.Dermatol Res Pract. 2015;2015:145409. doi: 10.1155/2015/145409. Epub 2015 Dec 15. Dermatol Res Pract. 2015. PMID: 26788051 Free PMC article.
-
IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells.Nat Commun. 2018 Jan 31;9(1):463. doi: 10.1038/s41467-018-02862-4. Nat Commun. 2018. PMID: 29386580 Free PMC article.
-
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.Stem Cell Res Ther. 2021 Sep 16;12(1):506. doi: 10.1186/s13287-021-02574-5. Stem Cell Res Ther. 2021. PMID: 34530920 Free PMC article.
-
Cell Therapy for Type 1 Diabetes: Current and Future Strategies.Curr Diab Rep. 2017 Jun;17(6):37. doi: 10.1007/s11892-017-0863-6. Curr Diab Rep. 2017. PMID: 28432571 Review.
-
Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease.Immun Inflamm Dis. 2023 Feb;11(2):e784. doi: 10.1002/iid3.784. Immun Inflamm Dis. 2023. PMID: 36840492 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials